IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells.
Cancer Lett
; 433: 147-155, 2018 10 01.
Article
in En
| MEDLINE
| ID: mdl-29969659
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Neoplasms
/
Interleukin-6
/
Drug Resistance, Neoplasm
/
Proto-Oncogene Proteins B-raf
/
STAT3 Transcription Factor
/
Vemurafenib
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Lett
Year:
2018
Type:
Article
Affiliation country:
Italy